EUVIMEDEUVIMED entdecken
Open Access

Metabolic pathways fuelling devil facial tumour diseases

Anne-Lise Gérard iD, Florence Pirard iD, Caitlin Vanbeek, Antoine M Dujon iD, Aaron G Schultz iD, Rodrigo K Hamede iD, Hannah V Siddle iD, Frédéric Thomas iD, Matthew McKenzie iD, Mark D Ziemann iD, Beata Ujvari iD

The FEBS Journal · 2026

DOI: 10.1111/febs.70420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2026. Verfasst von Anne-Lise Gérard und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Life and Environmental Sciences, Deakin University, Waurn Ponds, Australia. Hauptthemen laut MEDLINE: Facial Neoplasms, Marsupialia, Metabolic Networks and Pathways. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Victorian Operational Infrastructure Support Program, Hoffmann Family, Centre National de la Recherche Scientifique, International Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Devil Facial Tumour Diseases (DFTD), threatening Tasmanian devils, consist of two distinct transmissible cancers, DFT1 and DFT2, with differing origins and geographic spread. We investigated the metabolic differences between DFT1 and DFT2, examining cell viability, metabolic outputs, and bulk gene expression. Using both DFT1 and DFT2 cell lines and biopsies, we found that glycolysis, oxidative phosphorylation, glutamate metabolism, and fatty acid synthesis are all essential for the survival of both tumour types. However, DFT2 exhibited higher rates of glycolysis and lactate generation compared to DFT1. This coincided with elevated ATP production, cholesterol biosynthesis, and ROS generation, as well as an increased reliance on fatty acid metabolism. Furthermore, DFT2 is less metabolically adaptable than DFT1, being unable to switch to oxidative phosphorylation as DFT1 can when required. These metabolic changes in DFT2, in conjunction with its higher growth rate, suggest a more aggressive cancer phenotype than DFT1. Our findings highlight distinct metabolic adaptations in DFT2 that may contribute to its competitive advantage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Facial NeoplasmsMarsupialiaMetabolic Networks and PathwaysAnimalsOxidative PhosphorylationGlycolysisReactive Oxygen SpeciesMetabolic ReprogrammingCholesterolFatty AcidsHumansCell Line, Tumor

Stichwörter der Autor:innen

cancercholesterol biosynthesisglycolysispathway enrichmentreactive oxygen speciestranscriptomics

Substanzen

Reactive Oxygen SpeciesCholesterolFatty Acids

Autor:innen und Institutionen

  • School of Life and Environmental Sciences, Deakin University, Waurn Ponds, Australia.
  • Centre for Ecological and Evolutionary Cancer Research, MIVEGEC, University of Montpellier, CNRS, IRD, Occitania, France.
  • School of Natural Sciences, University of Tasmania, Hobart, Australia.
  • Queensland Alliance for Agriculture & Food Innovation, The University of Queensland, Brisbane, Australia.
  • Institute for Physical Activity and Nutrition, Deakin University, Burwood, Australia.
  • Burnet Institute, Melbourne, Australia.

ORCID-Profile: Anne-Lise Gérard, Florence Pirard, Antoine M Dujon, Aaron G Schultz, Rodrigo K Hamede, Hannah V Siddle, Frédéric Thomas, Matthew McKenzie, Mark D Ziemann, Beata Ujvari

Förderung

  • Victorian Operational Infrastructure Support Program
  • Hoffmann Family
  • Centre National de la Recherche Scientifique, International Research Project
  • Morris Animal Foundation
  • Australian Research Council
  • Save The Tasmanian Devil Eric Guiler Research Funds
  • NCRIS-funded Australian Research Data Commons (ARDC), Nectar Research Cloud
  • School of Life and Environmental Sciences, Deakin University

Zitieren

APA

Gérard, A. L., Pirard, F., Vanbeek, C., Dujon, A. M., Schultz, A. G., Hamede, R. K., Siddle, H. V., Thomas, F., McKenzie, M., Ziemann, M. D., & Ujvari, B. (2026). Metabolic pathways fuelling devil facial tumour diseases. The FEBS Journal. https://doi.org/10.1111/febs.70420

Vancouver

Gérard AL, Pirard F, Vanbeek C, Dujon AM, Schultz AG, Hamede RK, et al. Metabolic pathways fuelling devil facial tumour diseases. The FEBS Journal. 2026. doi:10.1111/febs.70420

BibTeX
@article{Grard2026,
  author = {Gérard, Anne-Lise and Pirard, Florence and Vanbeek, Caitlin and Dujon, Antoine M and Schultz, Aaron G and Hamede, Rodrigo K and Siddle, Hannah V and Thomas, Frédéric and McKenzie, Matthew and Ziemann, Mark D and Ujvari, Beata},
  title = {Metabolic pathways fuelling devil facial tumour diseases},
  journal = {The FEBS Journal},
  year = {2026},
  doi = {10.1111/febs.70420}
}
Kostenlos starten →